advanced Archives - tgiHealthCareerp

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

04/18/2021 (nivolumab), Adenocarcinoma, advanced, and, Approves, cancer, chemotherapy, Combination, Esophageal, expression, FDA, for, gastric, gastroesophageal, in, Junction, metastatic, of, Opdivo, or, Patients, PD-L1, regardless, status, with

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall

Medications

FDA Approves Libtayo (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-Small Cell Lung Cancer with PD-L1 Expression of ≥50%

02/22/2021 (cemiplimab-rwlc), ≥50%, advanced, Approves, cancer, Cell, expression, FDA, First-line, for, Libtayo, lung, Monotherapy, Non-Small, of, Patients, PD-L1, with

TARRYTOWN, N.Y. and PARIS, Feb. 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration

Health News

Drug May Boost Thinking Skills in People With Advanced MS

12/16/2020 advanced, Boost, Drug, in, may, MS, people, Skills, Thinking, with

WEDNESDAY, Dec. 16, 2020 — Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in

Health News

Preliminary results of two large immune therapy studies show promise in advanced cervical cancer

10/05/2020 advanced, cancer, cervical, immune, in, large, of, Preliminary, promise, results, show, studies, therapy, two

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy

Personal Health

Scientists use advanced imaging to map uncharted area of genome

09/03/2019 advanced, Area, genome, Imaging, map, of, Scientists, to, uncharted, use

Using advanced imaging techniques, researchers at the University of Colorado Anschutz Medical Campus have mapped a previously uncharted region of

Medications

Dacomitinib in advanced lung cancer: Disadvantages outweigh survival advantage

08/19/2019 advanced, advantage, cancer, Dacomitinib, Disadvantages, in, lung, outweigh, survival

Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced

Medications

Favorable five-year survival reported for patients with advanced cancer treated with the immunotherapy

07/25/2019 advanced, cancer, Favorable, five-year, for, immunotherapy, Patients, reported, survival, The, treated, with

A research team led by experts at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center

Health Problems

Telerehabilitation aids function, pain with advanced cancer

04/26/2019 advanced, AIDS, cancer, function, Pain, Telerehabilitation, with

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in

Health Problems

Study points to new strategy for boosting immunotherapy effectiveness in advanced colorectal cancer

03/21/2019 advanced, boosting, cancer, colorectal, Effectiveness, for, immunotherapy, in, New, points, strategy, Study, to

Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS as a possible explanation for